Stock Tip Tuesday…

🇺🇸$FDXTF 🇨🇦:$FNDX Leading the Nanotech Game

^_Company
FendX Technologies Charting a Path to Pathogen Control Through Nanotechnology…

Nanotechnology is an emerging industry with all sorts of applications across various sectors.

By manipulating materials at the atomic and molecular levels, nanotechnology enables the creation of products with enhanced properties, such as increased strength, reduced weight, and improved conductivity.

This capability drives innovation in fields like electronics, computing, construction, and especially in medicine where nanotechnology allows for new and improved products, advanced diagnostics, and regenerative therapies, leading to more effective healthcare solutions.

Thus, nanotechnology is poised to be a critical driver of innovation and economic growth in the coming years.

One of the newest companies in this nanotechnology revolution is FendX Technologies Inc (OTCQB: FDXTF | CSE: FNDX)

FendX Technologies Inc (OTCQB: FDXTF | CSE:FNDX) is focused on developing REPELWRAP™ film, which utilizes nanotechnology to repel bacteria, viruses, and liquids. This innovative film significantly reduces the spread of pathogens on surfaces, offering continuous protection. With 98% effectiveness against COVID-19 like viruses, E. coli, B. subtilis, and MRSA, FendX's technology could be a game-changer.

Why is FendX's technology so important? Pathogens can survive for extended periods on surfaces, leading to the spread of diseases. For example, the influenza virus can persist on surfaces like banknotes for up to 17 days, while the SARS-CoV-2 virus can survive for up to 28 days on materials like glass and steel. Current disinfecting practices are insufficient, requiring constant maintenance, whereas REPELWRAP™ film demonstrates continuous protection.

^_Stock
Why Investors Are Focused On FendX…

1. Massive Market Potential: The global demand for innovative products to keep surfaces clean continues to grow. The market for such products is expected to reach $1.3 billion by 2026. FendX's products in development, like REPELWRAP™ film, are anticipated to have several applications, potentially benefiting healthcare facilities, public transportation, schools, and offices.

2. Experienced Management Team: Dr. Carolyn Myers MBA, FendX's CEO, brings a wealth of experience in pharmaceuticals and healthcare. With a proven track record, including roles at Allergan PLC (now AbbVie) and Mylan (now Viatris), Dr. Myers provides solid leadership and under her guidance, FendX is meeting all its targets indicating a promising future.

3. Innovative Technology: Unlike other antimicrobial coatings that require pathogens to stick to metal ions, FendX's REPELWRAP™ film instantly repels pathogens. The nanotechnology creates a surface that pathogens can't attach to, significantly reducing their transmission.

4. Expert Production and Design: FendX's nanotechnology was discovered by scientists at McMaster University and licensed by FendX. The company has partnered with Dunmore for production, achieving a significant milestone by automating the manufacturing process of REPELWRAP™ film.

Exciting pipeline developments on FendX's horizon include nano-coated catheters and a spray nano-coating to protect high-touch surfaces. These products in development have the potential to keep people safer.

All in all FendX Technologies Inc (OTCQB: FDXTF | CSE: FNDX) presents an interesting opportunity to learn more about FendX and its innovative pre-commercialization film and the market excitement is building with the stock up over 100% YTD.

FendX Technologies (OTCQB: FDXTF | CSE: FNDX) is not one you want to miss!

Thank you
That’s All Folks

Thank you for reading. Like usual. Not financial advice. Always do your own research before investing. Small-Cap stocks are subject to high risk, so watch your ass!

Cheers,

Legal
Disclaimer

^{Refer to FendX Technologies Inc. website for their forward-looking statements - https://fendxtech.com/disclaimer/}

^{LEGAL DISCLAIMERS:}

^{PAID ADVERTISEMENT. This communication is a paid advertisement and is not a recommendation to buy or sell securities. VHLA Media and its owners, managers, employees, and assigns (VHLA Media”) has been paid twenty-five thousand Canadian Dollars (CAD$25,000) plus applicable taxes for an ongoing marketing campaign including this article among other things. This compensation is a major conflict with our ability to be unbiased. This communication is for entertainment purposes only. Never invest purely based on our communication.}

^{SHARE OWNERSHIP. The owners of VHLA Media may be buying and selling shares of this issuer for its own profit. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities. VHLA Media currently does not own any shares in FendX Technologies Inc}

^{NOT AN INVESTMENT ADVISOR. VHLA Media and its principals and agents are not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendations.}

^{ALWAYS DO YOUR OWN RESEARCH and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment.}

^{RISK OF INVESTING. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell securities. No representation is being made that any stock trade will or is likely to achieve profits. Comparisons made to other featured companies or past performance is not indicative of future results. Full disclaimer here - https://www.vhlamedia.com/terms-disclaimer}